Browse by Series:

FDA Approves MM-398, T-VEC, and Trabectedin, Cabozantinib RCC FDA Submission Started, New Pembrolizumab Data, and More

Laura Jones
Published: Saturday, Oct 31, 2015

Slider Left
Slider Right
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication